enVVeno Medical Corporation (NVNO)

NASDAQ: NVNO · IEX Real-Time Price · USD

5.66

-0.10 (-1.74%)

At close: Jul 19, 2024, 4:00 PM

5.71

+0.05 (0.88%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

enVVeno Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Revenue	0	0	0	0	0	0.03	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	-83.25%	Upgrade
Gross Profit	0	0	0	0	0	0.03	Upgrade
Selling, General & Admin	10.9	11.66	15.02	11.17	4.88	4.91	Upgrade
Research & Development	13.05	13.58	9.91	5.73	4.25	2.21	Upgrade
Other Operating Expenses	0	0	0	0	0	0.59	Upgrade
Operating Expenses	23.94	25.24	24.93	16.89	9.14	7.71	Upgrade
Operating Income	-23.94	-25.24	-24.93	-16.89	-9.14	-7.68	Upgrade
Interest Expense / Income	0	0	0	0	-0	-0.05	Upgrade
Other Expense / Income	-1.83	-1.72	-0.26	-0.37	0	-	Upgrade
Pretax Income	-22.12	-23.52	-24.67	-16.53	-9.14	-7.63	Upgrade
Net Income	-22.12	-23.52	-24.67	-16.53	-9.14	-7.63	Upgrade
Preferred Dividends	0	0	0	0	0.61	0	Upgrade
Net Income Common	-22.12	-23.52	-24.67	-16.53	-9.74	-7.63	Upgrade
Shares Outstanding (Basic)	16	12	11	9	1	1	Upgrade
Shares Outstanding (Diluted)	16	12	11	9	1	1	Upgrade
Shares Change	42.97%	9.54%	29.38%	572.10%	104.86%	68.34%	Upgrade
EPS (Basic)	-1.66	-1.91	-2.20	-1.90	-7.54	-12.10	Upgrade
EPS (Diluted)	-1.66	-1.91	-2.20	-1.90	-7.54	-12.10	Upgrade
Free Cash Flow	-17.34	-18.89	-15.73	-12.22	-7.86	-6.26	Upgrade
Free Cash Flow Per Share	-1.08	-1.54	-1.40	-1.41	-6.08	-9.93	Upgrade
Gross Margin	-	-	-	-	-	100.00%	Upgrade
Operating Margin	-	-	-	-	-	-24566.50%	Upgrade
Profit Margin	-	-	-	-	-	-24406.74%	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-20037.42%	Upgrade
EBITDA	-21.57	-22.97	-24.14	-16.08	-8.76	-7.28	Upgrade
EBITDA Margin	-	-	-	-	-	-23296.90%	Upgrade
Depreciation & Amortization	0.55	0.55	0.53	0.45	0.38	0.4	Upgrade
EBIT	-22.12	-23.52	-24.67	-16.53	-9.14	-7.68	Upgrade
EBIT Margin	-	-	-	-	-	-24566.50%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).